Acne scars are where the evidence is strongest. Niaz and colleagues' 2025 systematic review covered 16 studies and 481 patients, 6 of them randomised controlled trials. Their conclusion was hedged but positive: fractional RF microneedling "is likely an effective treatment for acne scarring when used as a monotherapy." They added that more randomised trials are needed to settle the right settings.
The single most useful trial is a head-to-head. Li and colleagues (2026) ran an evaluator-blinded split-face trial against fractional CO2 laser. Thirty-three people enrolled, 30 completed, 3 sessions at 8-week intervals. Acne scar scores fell from 54.73 to 30.53 on the RF microneedling side and from 53.67 to 31.03 on the CO2 side, with no significant difference between them. RF microneedling had shorter redness, pain, swelling and scabbing, and fewer post-inflammatory hyperpigmentation events.
That is the real argument for the treatment: for atrophic acne scars it delivered roughly the same result as an ablative laser, with less recovery and less pigment risk, in the same patients.
Neck and facial laxity have consistent but lower-tier support. A retrospective series of 98 people treated on the neck reported 73.3% average improvement at 3 months and 75.1% at 6 months in the group that had 3 sessions. A 33-person study measured the cervicomental angle - the angle under the chin - and found a 28.5 degree change at 6 months. A small split-face trial with an untreated control side found fewer wrinkles on the treated side at 6 months. Reviews of the field report improvement in texture and tightening across most studies, with satisfaction above 90% in many.
The honest framing is that these are cohorts, small split-face studies and satisfaction endpoints, not large randomised trials. The direction of the evidence is consistent. The strength of it is not high.
The evidence runs out at 6 months. Every controlled study in this class stops there. No randomised trial has measured outcomes at 24 or 36 months. A page or a consultation that promises you "1 to 3 years" is quoting nothing.
Most of the evidence above was not generated on the brand you are being sold. Almost no published study used Morpheus8 - a PubMed search returns 16 records and no randomised controlled trial. The research supporting RF microneedling comes from Lutronic Genius and Infini, Jeisys, Pollogen, Lumenis and several unnamed machines. The class evidence is real; it is just not any one brand's evidence.
No FDA clearance names any of the cosmetic uses. Morpheus8's clearances cover electrocoagulation and hemostasis (December 2019) and, since 2023, procedures "where coagulation/contraction of soft tissue or hemostasis is needed." Acne scars, wrinkles, laxity, cellulite, stretch marks, double chin, under-eyes and neck appear in none of them, and the same is true of most devices in this class. Off-label use is legal and routine in medicine, and a 510(k) clearance is a finding that a device is substantially equivalent to an earlier one - not proof that it works. But it does mean no regulator has reviewed evidence for the use you are being sold.
Complications are real. A 2026 analysis of the FDA MAUDE postmarket database covering January 2013 to October 2025 found 114 reports containing 224 events. Textural changes were 56 events (25.0%), pigmentary alteration 41 (18.3%), fat loss 26 (11.6%), inflammatory reactions 18 (8.0%), burns 14 (6.3%) and pain 12 (5.4%). The authors' own conclusion was that RF microneedling is generally safe but that significant complications can occur, and that experience and training matter.
Read those numbers correctly. MAUDE is voluntary, passive reporting with no denominator. There is no count of how many people were treated, so these are proportions of reported events and cannot be turned into a per-patient risk. Under-reporting in aesthetic medicine is severe. On the other side, a controlled 2024 study measured the submental fat layer by ultrasound in 30 people after RF microneedling and found no significant change, which is direct evidence against the idea that fat loss is routine.
Two uses the evidence does not support. Stretch marks: the best study, with 10 people completing, found no statistically significant global improvement, and the RF side was significantly more painful than CO2. Submental fat: there is no dedicated trial, and the one study that measured the fat layer found it unchanged. RF microneedling has evidence for tightening skin under the chin, not for removing fat there.
This is worth knowing before you weigh the reviews.
Two of the biggest recent papers were written partly by device-company staff. A 2026 systematic review of RF microneedling for facial rejuvenation, covering 22 studies and 558 participants, has 3 of 5 authors employed by or speaking for Jeisys Medical, a device manufacturer. The leading periorbital trial, with 24 patients, has 2 of 3 authors employed by Pollogen, the maker of the device used. The main dose-response paper has Lutronic-affiliated authors, one of them a company chief technology officer.
That does not make their findings false. It does mean independent replication matters more than usual. The most useful neutral map of the field is Tan and colleagues' 2021 critical review of 42 higher-quality studies, which has no apparent manufacturer conflict, and which counted 14 studies for skin rejuvenation, 7 for acne scars, 6 for acne, 5 for stretch marks, 5 for underarm sweating and 2 for melasma.
The only dated figure worth citing is RealSelf's $1,861 average for Morpheus8, updated 10 May 2024, based on 124 self-reported patient prices. Morpheus8 is the most heavily marketed brand in the class and sits at the expensive end of it, so this is one brand's crowdsourced number rather than a class average. The same source says prices start at $549 for a single session on one small area, and that a full series can cost upwards of $4,000.
State its limits alongside it. The prices are self-reported and unaudited. People who post reviews are not a random sample. The data is US-skewed. And it is now dated - it does not reflect 2025 or 2026 pricing.
No professional society publishes a price for this treatment. ASPS's 2023 report was the last to include minimally invasive physician fees, and even that report has no microneedling category; the 2024 report dropped minimally invasive fee data entirely. ASDS publishes procedure volumes, not prices. Any page claiming "the average cost according to industry surveys" is wrong.
Clinic pages quoting "$700 to $1,500 a session" are advertising their own prices. That is useful information about one clinic in one market at one time. It is not an average and should never be presented as one.
What actually moves the price: how much area is treated, how many sessions and whether they are packaged, the cost of the single-use tips (the main reason this costs far more than mechanical microneedling), the depth and applicator used, who performs it and in what setting, and add-ons such as PRP or exosomes billed on top.
It is a reasonable choice if:
It is a poor choice if:
A neutral test before you book. Would you still feel the money was well spent if the improvement you saw at 3 months faded over the following year and you never went back? If yes, the decision is proportionate to what is known. If no, you are relying on a durability claim that has never been measured.
If you get cold sores, say so when you book - not on the day. Antiviral medicine is started in advance, so it has to be prescribed before the appointment. There is no published data on cold-sore reactivation after RF microneedling specifically; the precaution is imported from laser resurfacing, where reactivation is well documented and prophylaxis is standard.
Also mention a pacemaker or implantable defibrillator, or metal implants near the treatment area. These are labelled contraindications for radiofrequency devices, and precautionary rather than tested.
Go to urgent or emergency care the same day if you have signs of a spreading infection:
Microneedling makes thousands of tiny channels in the skin, so a local infection can spread across the treated area. This is not something to wait out until your next appointment.